Soothesense Wart Remover Liquid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by a rough, "cauliflower-like" appearance on the surface, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. For optimal results, the wart may be soaked in warm water for approximately 5 minutes. After soaking, the area must be dried completely.

A sufficient amount of the medication should be applied using the provided brush to ensure complete coverage of each wart. It is important to allow the application to dry fully.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• Patients with a known allergy to any ingredient in this product.

• Individuals experiencing a burning sensation, redness, or swelling at the site of application.

• Application on moles, birthmarks, warts with hair, genital warts, or warts located on the face or mucous membranes is prohibited.

• Patients with diabetes or poor blood circulation should not use this product due to the increased risk of adverse effects.

Warnings and Precautions

For external use only. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a poison control center immediately.

This product should not be used by individuals who are allergic to any of its ingredients. Additionally, it is contraindicated in cases where there is a burning sensation, redness, or swelling at the site of application. The product must not be applied to moles, birthmarks, warts with hair growth, genital warts, or warts located on the face or mucous membranes.

Individuals with diabetes or poor blood circulation should refrain from using this product. If irritation or redness develops and persists, use should be discontinued immediately.

Healthcare professionals should advise patients to consult a doctor prior to use if they are pregnant or nursing. It is also essential to avoid contact with the eyes, nose, and mouth; should contact occur, the affected area must be rinsed thoroughly with water.

Side Effects

Patients using this product should be aware that it is intended for external use only. In clinical practice, some participants may experience irritation or redness at the application site. If such symptoms develop and persist, it is advised that patients discontinue use of the product.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Soothesense Wart Remover Liquid (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should not use this product if they are allergic to any of its ingredients. Prior to use, it is advisable for caregivers to consult a healthcare professional if the child is pregnant or nursing. This product is intended for external use only and should be applied with caution to avoid contact with the eyes, nose, and mouth; in the event of contact, the area should be rinsed thoroughly with water.

If any burning sensation, redness, or swelling occurs at the site of application, use should be discontinued immediately. The product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, it is contraindicated for use in pediatric patients with diabetes or poor blood circulation.

For application, the affected area should be washed, and warts may be soaked in warm water for 5 minutes before drying thoroughly. A sufficient amount of the product should be applied using the provided brush to cover each wart, allowing it to dry. This procedure may be repeated once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and nursing mothers should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

The use of this product during pregnancy or nursing should be approached with caution. It is advisable to consult a healthcare professional prior to use in these circumstances. No additional non-teratogenic effects or specific animal pharmacology and toxicology data have been provided.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a poison control center in the event of accidental ingestion of the product. It is essential to inform patients not to use the product if they have a known allergy to any of its ingredients.

Patients should be cautioned against using the product if they experience any burning sensation, redness, or swelling at the site of application. Additionally, they should be instructed not to apply the product on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes.

Healthcare providers should also emphasize that the product is not suitable for individuals with diabetes or poor blood circulation. Patients must be advised to discontinue use if any irritation or redness develops and persists.

It is important for healthcare providers to recommend that patients consult a doctor before using the product if they are pregnant or nursing. Furthermore, patients should be instructed to avoid contact with the eyes, nose, and mouth, and if such contact occurs, they should rinse the area thoroughly with water.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The bottle should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, it is advised to discard the product after opening if it is not used within a specified time frame, although this time frame is not detailed in the provided information.

Additional Clinical Information

The product is administered topically, with the recommended frequency being once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. Clinicians should advise patients not to use the product if they are allergic to any of its ingredients. Additionally, patients should consult a doctor prior to use if they are pregnant or nursing. It is important to avoid contact with the eyes, nose, and mouth; if contact occurs, patients should rinse thoroughly with water. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is advised.

Drug Information (PDF)

This file contains official product information for Soothesense Wart Remover Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)